![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » DENDRITE GIVES SHANGHAI SINE MEDICINE COMPANY THE ABILITY TO MEET THE UNIQUE NEEDS OF CHINESE PHARMACEUTICAL MARKET
DENDRITE GIVES SHANGHAI SINE MEDICINE COMPANY THE ABILITY TO MEET THE UNIQUE NEEDS OF CHINESE PHARMACEUTICAL MARKET
June 2, 2006
Dendrite International, Inc., a leading provider of pharmaceutical industry solutions, today announced a comprehensive three-year agreement to provide SINE Pharmaceutical Company Co., Ltd, a subsidiary of Shanghai Pharmaceutical Group Co., Ltd (SPGC) and pioneer in China's growing pharmaceutical market, with components of Dendrite's Sales Solutions.
Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060602005079&newsLang=en)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct